Study Shows Elevated Risk of Blood Clots and Arterial Blockage in Women Taking Birth Control Pills Containing Drospirenone

OAKLAND, Calif., Oct. 18, 2012 /PRNewswire/ -- A U.S. Food and Drug Administration-funded study led by the Kaiser Permanente Northern California Division of Research found an increased risk of arterial thrombotic events (ATE) and venous thromboembolic events (VTE) — commonly...